INS and metabolic syndrome: Furthermore, Tam treatment prevented HFD-induced obesity in OVX AF2ERKI females, suggesting that ERα AF-1 can control metabolic regulation without AF-2 activation but not the accompanying insulin insensitivity commonly seen in metabolic syndrome.